This Article Full Text Full Text (PDF) Submit a related Letter to the Editor Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Perrier, N. D. Articles by Clark, O. H. Search for Related Content PubMed PubMed Citation Articles by Perrier, N. D. Articles by Clark, O. H. Pubmed/NCBI databases Compound via MeSH Substance via MeSH Hazardous Substances DB PARATHYROID HORMONE

Parathyroid Surgery: Separating Promise from Reality

Departments of Surgery (P.H.G.I., O.H.C.), Nuclear Medicine (E.M.), and Laboratory Medicine (T.H., R.G.), University of California, San Francisco/Mount Zion Medical Center, and Surgical Service of Veteran’s Affairs (Q.-Y.D.), San Francisco, California 94143-1674

Address all correspondence and requests for reprints to: Nancy D. Perrier, Department of General Surgery, Wake Forest University, Medical Center Boulevard, Winston-Salem, North Carolina 27157. E-mail: . nperrier{at}wfubmc.edu

Abstract

We set out to determine the accuracy in predicting the success of biochemical and localizing studies for use in a minimally invasive parathyroidectomy. Preoperative sestamibi scans, intraoperative -probe examinations, and intraoperative PTH (IOPTH) monitoring were performed on a prospective cohort of patients.

Seventy-one patients were included in the study. Of the 59 patients (83%) with primary HPT, adenoma localization by sestamibi scanning was correct in 95% with solitary adenomas, but was correct in only 25% of the 14 patients with multiple adenomas. In patients with secondary and tertiary disease, sestamibi scanning incorrectly identified a single hot spot in 64% of cases. In no case of hyperplasia was the probe useful in locating other glands after a single gland was removed. IOPTH was accurate in 78% of patients with primary disease and in only 45% of patients with nonprimary disease.

A minimal approach can be considered in a select group of patients that does not have familial primary HPT, secondary or tertiary disease, coexisting thyroid pathology, or an equivocal sestamibi scan. Only patients with a positive single hot spot on sestamibi scan can be considered candidates. Using this criteria only 64% of all patients with hyperparathyroidism are candidates for a minimally invasive approach. The combination of a solitary hot spot on sestamibi scan and a fall in IOPTH allows the surgeon to make the correct decision regarding the need to convert to a bilateral approach in 93% of these selected patients.

This article has been cited by other articles:

				C M Ogilvie, P L Brown, M Matson, J Dacie, R H Reznek, K Britton, R Carpenter, D Berney, W M Drake, P J Jenkins, et al. Selective parathyroid venous sampling in patients with complicated hyperparathyroidism Eur. J. Endocrinol., December 1, 2006; 155(6): 813 - 821. [Abstract] [Full Text] [PDF]

				D. Rubello, M. R. Pelizzo, G. Boni, R. Schiavo, L. Vaggelli, G. Villa, S. Sandrucci, A. Piotto, G. Manca, P. Marini, et al. Radioguided Surgery of Primary Hyperparathyroidism Using the Low-Dose 99mTc-Sestamibi Protocol: Multiinstitutional Experience from the Italian Study Group on Radioguided Surgery and Immunoscintigraphy (GISCRIS) J. Nucl. Med., February 1, 2005; 46(2): 220 - 226. [Abstract] [Full Text] [PDF]

				O. Ugur, M. F. Bozkurt, E. Hamaloglu, C. Sokmensuer, I. Etikan, Y. Ugur, I. Sayek, and S. A. Gulec Clinicopathologic and Radiopharmacokinetic Factors Affecting Gamma Probe-Guided Parathyroidectomy Arch Surg, November 1, 2004; 139(11): 1175 - 1179. [Abstract] [Full Text] [PDF]

				K. Pacak, G. Eisenhofer, and D. S. Goldstein Functional Imaging of Endocrine Tumors: Role of Positron Emission Tomography Endocr. Rev., August 1, 2004; 25(4): 568 - 580. [Abstract] [Full Text] [PDF]

				K. Yao, F. R. Singer, S. I. Roth, A. Sassoon, C. Ye, and A. E. Giuliano Weight of Normal Parathyroid Glands in Patients with Parathyroid Adenomas J. Clin. Endocrinol. Metab., July 1, 2004; 89(7): 3208 - 3213. [Abstract] [Full Text] [PDF]

				D. Axelrod, J. C. Sisson, K. Cho, J. Miskulin, and P. G. Gauger Appearance of Ectopic Undescended Inferior Parathyroid Adenomas on Technetium Tc 99m Sestamibi Scintigraphy: A Lesson From Reoperative Parathyroidectomy Arch Surg, November 1, 2003; 138(11): 1214 - 1218. [Abstract] [Full Text] [PDF]

				G. Mariani, S. A. Gulec, D. Rubello, G. Boni, M. Puccini, M. R. Pelizzo, G. Manca, D. Casara, G. Sotti, P. Erba, et al. Preoperative Localization and Radioguided Parathyroid Surgery J. Nucl. Med., September 1, 2003; 44(9): 1443 - 1458. [Abstract] [Full Text] [PDF]

				O. H. Clark How Should Patients with Primary Hyperparathyroidism Be Treated? J. Clin. Endocrinol. Metab., July 1, 2003; 88(7): 3011 - 3014. [Full Text] [PDF]